In the treatment of glaucoma, the ability of continuous-wave (CW) transscleral laser photocoagulation (TSCPC) to lower intraocular pressure (IOP) must be weighed against its established risks.

IRIDEX Corp. has announced the launch of a new glaucoma procedure based on its MicroPulse technology, according to a news release. The non-invasive, in-office glaucoma therapy, a tissue-sparing, ...

MicroPulse ® Transscleral Laser Therapy (TLT), continuous-wave transscleral cyclophotocoagulation (CW-TSCPC), and MicroPulse Laser Trabeculoplasty (MLT) are non-incisional treatments that expand ways ...

Please provide your email address to receive an email when new articles are posted on . Dr. Noemi Lois is a clinical professor at Queen’s University Belfast and a consultant ophthalmologist and ...

Please provide your email address to receive an email when new articles are posted on . Micropulse transscleral cyclophotocoagulation lowered IOP in pediatric patients with refractory glaucoma, ...

The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...

MOUNTAIN VIEW, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced that in the second quarter of 2018 it has shipped the 1,000th unit of its Cyclo G6™ Laser ...

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories ...

MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...